Literature DB >> 11205231

Macrophage infiltration and angiogenesis in endometrial cancer.

I Hashimoto1, J Kodama, N Seki, A Hongo, Y Miyagi, M Yoshinouchi, T Kudo.   

Abstract

The aim of this study was to determine whether tumor-associated macrophages (TAMs) infiltration correlates with clinicopathological factors including microvessel, counts and clinical outcome in endometrial cancer. Overall 56 out of the 109 endometrial cancers (51.4%) expressed distinct tumor-associated macrophages infiltration in their tumor stroma. Tumor-associated macrophages infiltration was significantly high in tumors with deep myometrial invasion, high grade and elderly patients. Microvessel counts strongly correlated with tumor-associated macrophages infiltration in tumor stroma (p = 0.0002). However, tumor-associated macrophages infiltration was not a prognostic factor. In conclusion, tumor-associated macrophages may play a crucial role in the promotion of angiogenesis, but can not be used to prodict prognosis of patients with endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11205231

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.

Authors:  Yanping Ding; Nan Song; Yongzhang Luo
Journal:  Cancer Microenviron       Date:  2012-04-20

2.  CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway.

Authors:  Lu-Ying Li; Ke-Min Yin; Yi-Han Bai; Zhi-Gang Zhang; Wen Di; Shu Zhang
Journal:  Clin Exp Metastasis       Date:  2019-05-22       Impact factor: 5.150

3.  Silencing YKL-40 gene can inhibit inflammatory factor expression and affects the effect of THP-1 cells on endometrial cancer.

Authors:  Qin Luo; Jiangtao Fan; Lili Li
Journal:  Arch Gynecol Obstet       Date:  2021-08-21       Impact factor: 2.344

4.  Induced interleukin-8 expression in gliomas by tumor-associated macrophages.

Authors:  Tse-Ming Hong; Lee-Jene Teng; Chia-Tung Shun; Mei-Chen Peng; Jui-Chang Tsai
Journal:  J Neurooncol       Date:  2009-01-21       Impact factor: 4.130

5.  Identification of prognostic tumor-infiltrating immune cells in endometrial adenocarcinoma.

Authors:  Xin-Bin Pan; Yan Lu; De-Sheng Yao
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

6.  Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

Authors:  Qiong-wen Zhang; Lei Liu; Chang-yang Gong; Hua-shan Shi; Yun-hui Zeng; Xiao-ze Wang; Yu-wei Zhao; Yu-quan Wei
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

7.  Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.

Authors:  E Sivridis; A Giatromanolaki; I Papadopoulos; K C Gatter; A L Harris; M I Koukourakis
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

8.  Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness.

Authors:  E Blot; W Chen; M Vasse; J Paysant; C Denoyelle; J-Y Pillé; L Vincent; J-P Vannier; J Soria; C Soria
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

9.  The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.

Authors:  Sofia Edin; Maria L Wikberg; Anna M Dahlin; Jörgen Rutegård; Åke Öberg; Per-Arne Oldenborg; Richard Palmqvist
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.